Whilst demanding particular skills and expertise, the pharmaceutical and healthcare sectors today face commercial challenges common to many organisations within the broader process industries.
The concept of a recession-proofed sector is a dated perception, particularly when considering the high costs of product research, development, approval and general compliance.
Costs at all levels are under scrutiny, including those for design, engineering and plant construction. It is increasingly recognised that present day levels of investment and inherent need for flexibility demand appropriately sized and ‘fit for purpose’ supply organisations, working in partnership.
In such a difficult market place, combined with the need to sustain competitive advantage and accelerate new products to market, PM Group has the people and product mix to add value to its clients’ engineering functions.
The consolidation and growth of PM Group’s pharmaceutical business is a reflection of this evolution. PM Group enjoy Alliance and Approved Supplier agreements going back as far as 20 years with leading blue chips companies such as Sanofi, GlaxoSmithKline and Smith & Nephew.
Our engineering experience covers the full spectrum of requirements for this sector which includes a working knowledge of current Good Manufacturing Practise (cGMP). We have a track record for the concept development, design, construction, and commissioning of a multitude of process related equipment and systems including liquid and powder handling and storage, reactor control (including heat/cool options), isolation (eg glove box technology), filtration and drying.